EARLY FECAL CALPROTECTIN LEVELS PREDICT POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE: DATA FROM THE REPREVIO TRIAL

Lotte Oldenburg  1     Carlos Taxonera Samso  2     Antonio López San Román  3     Pilar Nos Mateu  4     Silvio Danese  5     Alessandro Armuzzi  6     Xavier Roblin  7     Laurent Peyrin-Biroulet  8     Rachel West  9     Ben J.M. Witteman  10     Marjolijn Duijvestein  11     Krisztina Barbara Gecse  1     Melanie Hulshoff  1     Nahid Mostafavi  12     Esmé Clasquin  1     Yoram Bouhnik  13     David Laharie  14     Geert R. D'Haens  15    
1 Amsterdam University Medical Center, Amsterdam, Netherlands
2 Hospital Clinico, Madrid, Spain
3 Hospital Ramon Y Cajal, Madrid, Spain
4 Hospital La Fe, Valencia, Spain
5 Instituto Clinico Humanitas, Rozzano, Italy
6 IBD Center, IRCCS Humanitas Research Hospital, Milan, Italy
7 University of St. Etienne, Saint Etienne, France
8 Nancy University Hospital, Vandoeuvre-les-Nancy, France
9 Sint Franciscus Gasthuis, Rotterdam, Netherlands
10 Ziekenhuis Gelderse Vallei, Ede, Netherlands
11 Radboudumc, Nijmegen, Netherlands
12 Amsterdam UMC, Amsterdam, Netherlands
13 CHU Beaujon, IBD and Nutrition, Clichy, France
14 CHU de Bordeaux Hopital Haut-Leveque, Pessac cedex, France
15 AMC Amsterdam Inflammatory Bowel Disease Centre, Amsterdam, Netherlands

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing